Abstract
Recommending nitrofurantoin to treat uncomplicated cystitis was associated with increased nitrofurantoin use from 3.53 to 4.01 prescriptions per 1,000 outpatient visits, but nitrofurantoin resistance in E. coli isolates remained stable at 2%. Concomitant levofloxacin resistance was a significant risk for nitrofurantoin resistance in E. coli isolates (odds ratio [OR], 2.72; 95% confidence interval [CI], 1.04-7.17).
MeSH terms
-
Ambulatory Care
-
Anti-Infective Agents, Urinary / pharmacology*
-
Case-Control Studies
-
Colorado
-
Cystitis / drug therapy*
-
Cystitis / microbiology*
-
Drug Resistance, Multiple, Bacterial
-
Drug Utilization
-
Escherichia coli / drug effects
-
Escherichia coli Infections / drug therapy*
-
Escherichia coli Infections / epidemiology
-
Female
-
Humans
-
Levofloxacin / pharmacology*
-
Nitrofurantoin / pharmacology*
-
Practice Guidelines as Topic
Substances
-
Anti-Infective Agents, Urinary
-
Levofloxacin
-
Nitrofurantoin